Detection of lymph node metastases by contrast-enhanced MRI in an experimental model

Magnetic Resonance in Medicine

Volumn 47, Issue 2, 2002, Pages 292-297

  Wunderbaldinger, Patrick ^a,b   Josephson, Lee ^a,b   Bremer, Christoph ^a,b   Moore, Anna ^a,b   Weissleder, Ralph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Contrast media; Iron oxide; Lymphatic system; Metastases; MRI

Indexed keywords

CONTRAST MEDIA; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAMMALS; TUMORS;

CONTRAST-ENHANCED; EXPERIMENTAL MODELING; GREEN FLUORESCENT PROTEIN; LYMPH NODE METASTASIS; LYMPHATIC SYSTEMS; METASTASES; SIGNAL-TO-BACKGROUND RATIO; WESTERN BLOT METHOD;

PATHOLOGY;

CONTRAST MEDIUM; GREEN FLUORESCENT PROTEIN; INDIUM 111;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL MODEL; FEMALE; LYMPH NODE METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PROTEIN EXPRESSION; SIGNAL DETECTION; WESTERN BLOTTING;

EID: 0036163289     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10068     Document Type: Article

References (28)

1. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
2. Metastases in small lymph nodes from colon cancer
3. MRI of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): Preliminary observations
4. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation
5. Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer
6. Lymph node metastases: Safety and effectiveness of MRI with ultrasmall superparamagnetic iron oxide particles-initial clinical experience
7. MRI of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide
8. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET
9. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma
10. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
11. Experimental lymph node metastases: Enhanced detection with MR lymphography
12. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma
13. Biological behavior of malignant melanoma cells correlated to their survival in vivo
14. A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread
15. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
16. MR lymphography: Study of a high-efficiency lymphotrophic agent
17. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells
18. Physical properties of MION-46 and AMI-227
19. One-dimensional gel electrophoresis
20. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration
21. Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI)
22. Lymph nodes: Microstructural anatomy at MRI
23. MR lymphography using iron oxide nanoparticles in rats: Pharmacokinetics in the lymphatic system after intravenous injection
24. Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes
25. AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumor-bearing lymph nodes
26. Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MRI
27. Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MRI
28. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages